Zhang M, Xuan S, Bouxsein ML, Von Stechow D, Akeno N, Faugere MC, et al
Careful research is needed to distinguish true medication effects from associations driven by underlying patient risk factors. Dimitra Skondra, MD, PhD We should take this signal seriously and work collaboratively across specialties to design well-controlled prospective studies that can more definitively answer whether there is a causal relationship, Skondra said
Additionally, Mounjaro , one of the newer diabetes drugs, which was approved in May 2022 and has a unique dual mechanism of action (it activates the GLP-1 hormone as well as another hormone called the glucose-dependent insulinotropic polypeptide or GIP, both helping to improve blood sugar) may be even more effective than semaglutide in reducing weight
2g Sugars
Thng hiu: Dr Lacir Xut x: Vit Nam M SP: SHCH11451-O72017 - H tr iu tr nm tn gc, lm m tn nhang, cc vit thm sm
speaker fees from AstraZeneca, Boehringer Ingelheim, Janssen, Merck and Novo Nordisk